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X-Ray Dark-field Imaging to Depict 
Acute Lung Inflammation in Mice
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The aim of this study was to evaluate the feasibility of early stage imaging of acute lung inflammation 
in mice using grating-based X-ray dark-field imaging in vivo. Acute lung inflammation was induced 
in mice by orotracheal instillation of porcine pancreatic elastase. Control mice received orotracheal 
instillation of PBS. Mice were imaged immediately before and 1 day after the application of elastase or 
PBS to assess acute changes in pulmonary structure due to lung inflammation. Subsequently, 6 mice 
from each group were sacrificed and their lungs were lavaged and explanted for histological analysis. 
A further 7, 14 and 21 days later the remaining mice were imaged again. All images were acquired with 
a prototype grating-based small-animal scanner to generate dark-field and transmission radiographs. 
Lavage confirmed that mice in the experimental group had developed acute lung inflammation one day 
after administration of elastase. Acute lung inflammation was visible as a striking decrease in signal 
intensity of the pulmonary parenchyma on dark-field images at day 1. Quantitative analysis confirmed 
that dark-field signal intensity at day 1 was significantly lower than signal intensities measured at the 
remaining timepoints, confirming that acute lung inflammation can be depicted in vivo with dark-field 
radiography.
Acute lung inflammation is characterized by decreased endothelial cell barrier function, increased vascular per-
meability and influx of neutrophils leading to the development of acute bilateral, pulmonary infiltrates, followed 
by impaired oxygenation1. These pathomechanisms play an important role in the development of acute lung 
injury (ALI), a severe form of acute respiratory distress syndrome (ARDS) in humans. Acute lung inflammation 
can occur either after direct (e.g. due to pneumonia, toxic inhalation) or indirect damage of pulmonary paren-
chyma (e.g. trauma, sepsis)2. With a mortality rate of 40–50% ARDS represents one of the most deadly lung 
diseases3. About 30% of patients initially diagnosed with mild ARDS will progress to moderate and severe forms 
of the disease4, pointing out how vital early diagnosis of acute lung inflammation is. Reliable diagnosis remains 
challenging, as clinical signs are rather unspecific, leading to a high number of misdiagnoses5.
Chest radiography is still the most frequently used radiological tool to diagnose and monitor lung inflam-
mation6. Radiographic findings, such as bilateral lung opacities, that can either appear diffuse, patchy or 
homogenous, reflect interstitial or alveolar edema7–9. However, as these signs are nonspecific and can occur in 
different kinds of pulmonary edema (e.g. due to heart failure), high interobserver variability is found in chest 
radiograph-based diagnosis of acute lung inflammation10.
Computed tomography (CT) of the lung is more accurate than chest radiography in detecting underlying 
causes as well as complications of acute lung response. Although CT is the gold standard in diagnosing lung 
inflammation, difficulties and risks of moving patients from intensive care units as well as the comparatively high 
radiation dose limits its use11,12.
X-ray dark-field projection radiography could be a potential solution to this problem as it might provide 
important information to pathological findings in transmission images without adding the inconveniences linked 
to CT.
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Dark-field images are generated by implementing a three grating Talbot-Lau interferometer in between the 
X-ray source and detector, and moving one of the gratings perpendicular to the beam over one grating period. 
Applying Fourier analysis to the intensity registered in each pixel for all grating positions yields conventional 
transmission, differential phase-contrast and dark-field images. The dark-field image visualizes small-angle scat-
tering of X-rays within tissue. Due to its alveolar microstructure healthy lung parenchyma generates a strong 
dark-field signal, which decreases in various lung diseases that affect the integrity of the alveoli. Phase-contrast 
images visualize the phase-shift of X-ray beams within tissue with enhanced representation of edges, making large 
airways such as the trachea or main bronchi visible13–15.
Diagnosing lung disorders is of particular interest due to the strong dark-field signal generated by pulmonary 
tissue. Added diagnostic value of dark-field compared to transmission imaging has been shown for various lung 
diseases, such as pneumothoraces16, emphysema17, fibrosis18 and bronchopulmonary dysplasia19. Based on these 
promising results we now aimed at investigating the value of dark-field imaging for the diagnosis of acute lung 
inflammation.
The purpose of the present study was to evaluate whether imaging pathological changes due to acute lung 
response in vivo is possible using this new imaging technique, to correlate observed alterations in dark-field signal 
intensities with histopathology as well as with signal changes in transmission images and to discuss a potential 
added diagnostic value of dark-field over transmission imaging.
Results
Elevated neutrophil recruitment into the lung and subsequent emphysema development. To 
investigate the development of acute inflammatory response, we analyzed differential and total cell number in 
bronchoalveolar lavage (BAL) fluid and performed histology in porcine pancreatic elastase (PPE) and phosphate 
buffered saline (PBS) treated age-matched mice. We found that a mean number of 4.4 × 104 ± 1.0 × 104 leucocytes 
were counted in lavages of control animals, compared to a strongly increased number of 1.6 × 105 ± 5.4 × 104 
leucocytes in animals that had received PPE the previous day (p = 0.004; Fig. 1).
No significant difference was found in numbers of macrophages (p = 0.87), whereas numbers of neutro-
phils and lymphocytes were significantly higher for animals in the experimental group (neutrophils: 1.1 × 105 
± 4.6 × 104; lymphocytes: 3.4 × 103 ±1.6 × 103) compared with cell counts in the control group (neutrophils: 
2.4 × 103 ± 2.8 × 103, p < 0.004; lymphocytes: 1.4 × 103 ± 1.5 × 103, p = 0.04). As an additional sign of lung injury, 
lavages in the experimental group showed a reddish color, typical for fluid enriched with erythrocytes, compared 
to a clear appearance of lavages in the control group. 21 days after application of elastase the number of leucocytes 
had returned to baseline (3.9 × 104 ± 1.4 × 104; p = 0.1 compared to control group at day 21), indicating that the 
acute inflammatory reaction had stopped.
Representative examples of haematoxylin and eosin (H&E) stained sections from control lungs and lungs sur-
gically extracted 1 and 21 days after application of elastase are presented in Fig. 2A and B. Histologic data shows 
hyperemia, alveolar hemorrhage, mononuclear/neutrophilic infiltrates and numerous alveolar macrophages 
(black arrows) after 1 day of elastase treatment. These alterations were not found in the control lung and the lung 
21 days after induction of emphysema (Fig. 2B).
Figure 2 also demonstrates that after only 1 day of elastase application, there is an enlargement of the air-
spaces, which is significantly worsened at day 21. To quantify the changes in airspace enlargement induced by 
elastase treatment, mean cord length (MCL) was measured using a computer assisted stereological toolbox. 
MCL-quantification confirmed that early pulmonary emphysema had developed one day after orotracheal appli-
cation of elastase: MCL was 65.2 ± 7.1 μm in the elastase group, compared to 32.6 ± 11.7 μm in the control group 
(p < 0.001). 21 days after treatment with elastase, severe emphysema was found as indicated by a significantly ele-
vated MCL level of 111.2 ± 10 μm (p < 0.001 compared to control and day 1 after application of elastase) (Fig. 3).
Figure 1. BAL cell counts. Total and differential cells counted in bronchoalveolar lavages of animals in the 
control group and experimental group at day 1 and day 21 after application of PBS or elastase. *p < 0.05.
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These results indicate that elastase induced severe acute lung inflammation and mild pulmonary emphy-
sema one day after application, with emphysema progressively worsening over time despite a resolution of 
inflammation.
Figure 2. Representative H&E stained lung sections of a control mouse (upper row) and a mouse of the 
experimental group 1 day (middle row) and 21 days (lower row) after application of elastase. (A) Overview, (B) 
magnification for detailed analysis. Tissue macrophages are indicated by black arrows in (B).
Figure 3. Mean cord length of animals 1 day (white bar) and 21 days (grey bar) after application of PBS or 
elastase. *p < 0.05.
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Qualitative evaluation of radiographs. To evaluate the potential of X-ray dark-field imaging to image 
acute lung injury, we analyzed the animals in vivo before and after PPE treatment on days 0, 1, 7, 14 and 21.
Figure 4 gives an example of two mice, one control mouse (A) that was scanned prior to PBS application and 
one mouse of the experimental group (B) that received elastase immediately after the first scan. Both mice were 
additionally imaged 1 day and 21 days after application of PBS or elastase. As shown in A, the mouse in the control 
group does not show any alterations in signal intensities at any point in time, neither in the transmission nor in 
the dark-field image. By contrast, in B changes of a mouse’s lung due to acute lung injury caused by application of 
elastase are revealed. Whereas the lung appears healthy at day 0, it shows a strong loss in dark-field signal intensity 
at day 1. Correspondingly, partially confluent opacities due to inflammation can be observed in the transmission 
image. After 21 days this mouse’s lung generates a slightly increased dark-field signal compared to day 1 but still 
shows an obvious signal loss compared to day 0. When assessing the corresponding transmission image 21 days 
after application of elastase only subtle, indirect signs of pulmonary emphysema are detected, such as an enlarged 
lung volume leading to lowered diaphragms.
Quantitative evaluation of radiographs. To evaluate whether alterations in lung parenchyma due to 
injection of PPE are quantifiable in radiographic images, the development of transmission (A) and dark-field (B) 
signal intensities over time (Fig. 5) was monitored.
No statistically significant change in transmission signal intensities between time points was observed within 
either treatment group (p > 0.5). However, a significant difference in the transmission signal was detected 
between the experimental and control groups at day 14 (p = 0.01) and day 21 (p = 0.01). Between time points, no 
changes in dark-field signal intensity was observed for the control group (p > 0.5), whereas in the experimental 
group signal intensity was significantly lower at day 1 compared to all other timepoints (p < 0.5). From day 1 
on, dark-field signal intensities were significantly lower compared to day 0 (p < 0.5). There was no statistically 
significant difference between the dark-field signal intensities of days 14 and 21 within the experimental group. 
Between both groups, a significant difference in the dark-field signal intensity was measured at day 1 (p = 0.002) 
as well as days 7, 14 and 21 (p = 0.01 each).
Figure 4. Visual example for X-ray transmission (upper row) and X-ray dark-field (lower row) images of mice 
before (Day 0), one day and 21 days after treatment with PBS (A) or elastase (B).
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Quantitative histogram evaluation. To investigate the discriminability of the transmission and 
dark-field signal between healthy and pathological specimen, a basic histogram analysis was performed com-
paring controls and treated animals at day 1 (Fig. 6). While the signal distributions of PBS and elastase treatment 
widely overlap in the transmission channel, a distinct separation was obtained for the relative visibility data. 
Despite its wider distribution, the discriminability between controls and treated animals is 4.12-times higher for 
the relative visibility compared to the transmission signal.
Discussion
Acute lung inflammation is a potentially life threatening condition. Early diagnosis is essential to prevent aggrava-
tion of this disease. As conventional transmission radiography is neither highly sensitive nor specific concerning 
lung imaging20, making a diagnosis can be challenging. Due to its higher sensitivity dark-field lung imaging might 
offer a potential solution to this problem.
This study demonstrates for the first time that in vivo imaging of acute lung response using dark-field radi-
ography is feasible. Due to the strong dark-field signal derived from healthy lung tissue, inflammation-driven 
development of acute, bilateral infiltrates, can be clearly visualized, representing a substantial improvement over 
conventional transmission X-ray imaging.
Transmission images showed subtle, but typical signs of acute lung inflammation, such as diffuse lung opac-
ities. However, when evaluated quantitatively, transmission signal intensities did not alter significantly in acute 
lung injury. Moreover, transmission images did not conclusively demonstrate the progression of emphysema, 
which is in agreement with earlier studies17. Since lung tissue only weakly absorbs X-rays, changes in lung 
architecture lead to a minor change in signal intensity, often too weak to be detected visually21 or quantitatively. 
Furthermore, as X-ray beams are attenuated by soft tissue, transmission signal strength, unlike dark-field sig-
nal intensity, greatly depends on the overlying chest wall. Hence, transmission signal intensities within the lung 
parenchyma are always influenced by overlaying structures, complicating the diagnosis of lung diseases. In con-
trast, it is possible to image acute lung injury, as shown by qualitative and quantitative analysis of the dark-field 
signal. At day 1, a maximum loss in signal strength can be observed in the dark-field images, indicating the 
presence of acute lung inflammation. This was confirmed by BAL and histology as lavages showed a substantial 
increase of leucocytes indicative of inflammation22. The observed changes in signal strength are not related to 
Figure 5. Quantitative analysis of acute lung inflammation development over time. Medians of pulmonary 
signal intensities measured in transmission (A) and dark-field (B) images of control (white circles) and 
experimental animals (black squares). Ranges are indicated by black bars. #p < 0.05 at one timepoint between 
experimental and control group. *p < 0.05 between different timepoints within experimental or control group.
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the instillation of mere liquid as one day after application of PBS, in the control group, there was no alteration in 
signal intensities found, indicating complete resorption of the fluid. 21 days after elastase treatment, as well as in 
the control groups, neither in BAL nor in histopathology an inflammatory reaction could be observed. This acute 
rise in the total number of leucocytes in BAL at day 1 after elastase instillation is mainly driven by neutrophils, 
which is consistent with literature23,24. As BAL shows, the count of macrophages in the bronchial spaces is stable. 
However, histopathology indicated that the quantity of macrophages in the lung alveoli strongly increased. A 
possible explanation for this observation is most likely based on the fact, that BAL does not reach the smallest, 
most peripherally located airways where tissue macrophages are located.
MCL quantification highlights, that development of acute lung inflammation as well as emphysema is occur-
ring at the same time: both are measurable one day after application of elastase. This represents a challenge for 
isolating the effects of each of these processes. Elastase is typically used to induce pulmonary emphysema in 
mice and therefore is not a specific disease model for lung inflammation. Nonetheless, it is well known that 
intratracheal instillation of elastase causes an acute lung response, manifesting in alterations of the integrity of 
the alveolar-capillary barrier, with consequent alveolar flooding, hemorrhage and recruitment of inflammatory 
cells referred to as diffuse alveolar damage25, which we were able to depict with BAL and histology one day after 
application of elastase. Moreover, correlating the data from quantitative image analysis with both, MCL quan-
tifications and results from BAL, indicates that the alterations in dark-field signal intensity observed at day 1 is 
not exclusively due to the development of emphysema. Only 1 day after instillation of elastase the development 
of only mild emphysema can be expected, which cannot be responsible for the immense loss in dark-field signal 
intensity even exceeding that measured at day 21. The signal development at day 1 is mainly due to changes in 
acute lung inflammation, such as alveolar edema, minimizing air in the alveoli and therefore leading to a very 
weak dark-field signal. This is confirmed by the corresponding transmission images. Although the measurable 
changes in transmission signal intensity might not be significant we clearly find diffuse lung opacities indicating 
infiltrates caused by application of elastase 1 day prior. The time curve of the measured dark-field signal endorses 
this assumption. There is a significant dip of the dark-field signal at day 1 compared to the signal strength at day 
7 and even at day 21, indicating the presence of a severe infiltrate on top of early pulmonary emphysema. Only 
seven days after application of elastase, the dark-field signal intensity has significantly increased compared to 
day 1, which – as pulmonary emphysema is further developing and therefore should lead to an increasing loss of 
dark-field signal intensity- is explained by a decline in inflammation. As pulmonary emphysema is developing 
over time, we find a constant reduction of dark-field signal strength from day 7 on until day 21 – as mentioned 
before – never reaching the level of maximum signal loss observed at day 1, which is mainly due to inflammatory 
processes in the lungs. However, to definitely exclude the influence of emphysematous changes a disease model 
specifically designed for lung inflammation should be applied in future studies26.
This work is a feasibility study with a small number of animals. Since it was designed as a longitudinal study, 
histological correlation, proving that the signal changes observed in dark field images at day 7 and 14 represent 
the real degree of lung destruction, is not available. However, a previous study focusing on grading different 
stages of emphysema with dark-field radiography showed an excellent correlation between emphysema severity 
and histology17. Therefore, dark-field images acquired at these interim time points can reasonably be assumed to 
reflect the true degree of lung destruction.
Animals were breathing freely at a respiratory rate of approximately 120 breaths per minute, which might 
result in some blurring especially in the peripheral regions of the lungs.
Figure 6. Histogram representation of PBS and elastase treatment comparing attenuation and scatter 
information at day 1. Individual (light) and group wise summed (dark) signal values extracted of the segmented 
lung regions. Similar signal values were obtained within the individual groups. A pronounced distribution 
separation was only observed in the relative visibility signal. Mean (☐) and width (☐) of the merged 
distribution for the histogram analysis were obtained by a Gaussian fit.
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Furthermore, a number of technical challenges, such as a larger field of view and further dose reduction (ani-
mal dose/acquisition 1–1.5 mGy) need to be solved with regard to a potential clinical application in humans22.
To conclude, our study suggests that dark-field radiography allows for significantly more sensitive detection 
of acute lung inflammation in mice compared to conventional transmission imaging. Combining the high sensi-
tivity provided by dark-field imaging with the rather specific information of transmission images might lead to a 
maximum efficiency in the diagnosis of acute lung inflammation.
Materials and Methods
Small animal protocol. Acute lung inflammation was induced by instillation of 80 μl porcine pancreatic 
elastase (PPE, Sigma-Aldrich, Munich, Germany) dissolved in sterile phosphate-buffered saline (80 U/kg body 
weight) in the trachea of pathogen-free female C57BL/6 N mice (Charles River Laboratories, Sulzfeld, Germany, 
n = 11), aged eight to ten weeks27. Endotracheal application of PPE in mice is typically used as a model of pul-
monary emphysema, which develops over the course of several weeks. In this study, we used the same mouse 
model to study the acute lung injury that occurs as an immediate response to the instillation of PPE. Control 
mice received 80 μl sterile phosphate-buffered saline (n = 10). Animals were imaged immediately before and 
one day after application of elastase or PBS to assess early changes in pulmonary structure. Mice were breathing 
freely during image acquisition. Respiratory frequency as well as body temperature was monitored while the 
pulmonary scans were performed. To protect the animals from hypothermia, a built-in fan kept the temperature 
inside the scanner constantly warm. Following image acquisition, 6 animals out of each group were sacrificed. 
By rinsing the lungs 3-times with 0.5 ml sterile PBS using a tracheotomy cannula, bronchoalveolar lavages (BAL) 
were acquired. Lungs were subsequently fixed by intratracheal instillation of 6% paraformaldehyde for further 
histological analysis. The remaining mice (n = 5 in the experimental group, n = 4 in the control group) were 
imaged 7, 14 and 21 days after application of PBS or elastase. At day 21 these animals were sacrificed, BALs were 
performed as described and the lungs were obtained for histopathological processing. Intraperitoneal injection of 
midazolam (5 μg/kg body weight), fentanyl (50 μg/kg body weight) and medetomidine (500 μg/kg body weight) 
served as anesthesia for PBS/elastase application and image acquisition.
All experiments were carried out according to national (Gesellschaft fuer Versuchstierkunde) and interna-
tional (Federation of Laboratory Animal Science Associations) animal welfare guidelines. The experiments were 
approved by the local government for the administrative region of Upper Bavaria, Germany.
Imaging Protocol. All images were acquired in a supine position using a prototype small-animal scan-
ner28,29. The scanner’s grating interferometer consists of three gratings: a gold source grating (period (p) = 10 μm, 
height (h) = 35 μm), a nickel phase grating (p = 3.24 μm, h = 4 μm; distance to source grating 30 cm) and a gold 
analyzer grating (p = 4.8 μm, h = 45 μm; distance to source grating 45 cm). The scanner was operated with five 
stepping positions of the source grating. The source ran at 35 kVp and 20 W source power with an exposure time 
of five seconds per stepping position. The field-of-view was round with a diameter of 5 cm and a spatial resolution 
of 57 μm (10% MTF). Using Matlab (Mathworks Inc., MA, USA) post-processing of the acquired images was 
performed.
Bronchoalveolar Lavage and cell counts. BAL was centrifuged at 400 G for 10 minutes and the result-
ing cell pellet re-suspended in RPMI-1640 medium (Gibco, Life Technologies, Darmstadt, Germany) for the 
total cell count using a hemocytometer. Cytospins of the cell suspension were then prepared and stained using 
May-Grünwald-Giemsa for differential cell counting (200 cells/sample).
Histology. The right lung was snap frozen in liquid nitrogen for further analysis. The left lung was fixed under 
a constant pressure of 20 cm by intratracheal instillation of 6% paraformaldehyde and using systematic uniform 
random sampling embedded into paraffin for Hematoxylin and Eosin (H&E)-stained histological analysis and 
immunohistochemistry. Images of stained sections were obtained using a Mirax Desk (Carl Zeiss MicroImaging 
GmbH, Göttingen, Germany) slide scanner and analysed using Pannoramic Viewer version 1.15.2 (3DHistech 
Kft, Budapest, Hungary).
Quantitative Morphometry. Using an Olympus BX51 (Olympus, Germany) light microscope equipped 
with a computer-assisted stereologic toolbox (newCAST, Visiopharm, Hoersholm, Denmark), lungs were ana-
lyzed with design-based stereology. Histological evaluation of the lungs was performed using slices of pulmonary 
tissue that covered the entire cross-section of the right and the left lung in axial plane. Within one slice, 35 ran-
domly selected regions of interest were analyzed with a computer-aided system as specified through published 
guidelines for MCL-quantification30. Mean cord length (MCL) was measured by superimposing a line grid on the 
images of lung sections at a 20-times magnification. Points on the lines of the grid hitting the air spaces as well as 
intercepts of the lines with alveolar septa were counted to calculate MCL in μm pursuant to the equation:
=
Σ ⋅
Σ ⋅ .
MCL P L p
I
( )
0 5
air
septa
wherePair are the points of the grid hitting air spaces, L(p) is the line length per point and Isepta are the inter-
cepts of alveolar septa with grid lines31.
Quantitative Image Analysis and Histogram Analysis. Regions of interest (ROIs) were defined to 
quantify dark-field and transmission signal intensities in the lung. These pentagonally shaped ROIs were placed 
manually into the images to capture as much lung tissue as possible. The mediastinal shadows as well as all osse-
ous thoracic structures were excluded. The latter was done to avoid distortion of the transmission signal by the rib 
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cage17. For the histogram analysis transmission and relative change of visibility were compared whereas their 
negative logarithm was used for quantitative comparison with MCL values as both signals scale exponentially 
with the samples thickness. The dataset utilized for the histogram analysis is depicted in Fig. 6. It consists of the 
group-wise summed signal values extracted of the aforementioned segmented lung regions. Within the individual 
groups and modalities similar histograms were obtained as indicated in Fig. 6. For this reason, a merge of the data 
for the histogram analysis is justified. A Gaussian function was fitted to the data to obtain mean µ( ) and width (σ) 
of the respective distributions. The ratio of the mean distances with respect to the distributions width of the 
respective modalities serves as a performance indicator to compare the two imaging modalities in terms of dis-
criminability between PBS and elastase treatment:
μ − μ
σ + σ
μ − μ
σ + σ
Vis
Tra
[ ]
[ ]
ELA PBS
ELA PBS
ELA PBS
ELA PBS
Statistical analysis. Means and standard deviations of cell counts for mean cord length (MCL) and bron-
chopulmonary lavage of the control and experimental group were calculated. Means were tested for statistical 
significance using Student two-tailed t-test for paired samples. Medians and ranges of dark-field and trans-
mission signal intensities derived from the lung tissue were calculated for all animals. Medians were compared 
between the control and experimental group using Mann-Whitney-test and within one group using Friedman 
test. MedCalc® (version 15.2.2, Ostend, Belgium) was used as statistical software.
Data availability statement. All data generated or analyzed during this study are included in this pub-
lished article.
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